Origin Therapeutics Holdings, Inc. Balance Sheet
Origin Therapeutics Holdings, Inc.'s total assets for Q3 2024 were $1.63M, a decrease of -28.55% from the previous quarter. TSE:SPLY total liabilities were $347.61K for the fiscal quarter, a -37.16% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.